Moray Medical is developing the Coral system, an interventional robotics platform powered by microfluidics and an augmented reality (AR) digital user interface. The Coral platform is intended to simplify a wide range of minimally invasive cardiovascular interventions while initially targeting the transcatheter mitral valve repair (TMVR) market. The company says the platform is designed to empower interventionalists at all skill levels and to enable cost‑efficient procedures. Moray aims to expand access so that more patients who are currently untreated can receive life‑saving interventions. The company will use the new funding to continue development of the Coral system. Moray is headquartered in Mountain View, Calif.

Total raised

$6M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2021